Next Article in Journal
Structure, Dynamics, and Ligand Recognition of Human-Specific CHRFAM7A (Dupα7) Nicotinic Receptor Linked to Neuropsychiatric Disorders
Next Article in Special Issue
Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5′AMP-Activated Kinase Inactivation
Previous Article in Journal
Exposure to the Methylselenol Precursor Dimethyldiselenide Induces a Reductive Endoplasmic Reticulum Stress in Saccharomyces cerevisiae
Previous Article in Special Issue
MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia
Article

Urolithin A and B Alter Cellular Metabolism and Induce Metabolites Associated with Apoptosis in Leukemic Cells

1
Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Centre of Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah 21589, Saudi Arabia
*
Author to whom correspondence should be addressed.
These Author’s share equal contribution.
Academic Editors: Giovanni Martinelli and Cristina Papayannidis
Int. J. Mol. Sci. 2021, 22(11), 5465; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115465
Received: 19 March 2021 / Revised: 22 April 2021 / Accepted: 13 May 2021 / Published: 22 May 2021
(This article belongs to the Special Issue Metabolism and Leukemia: From Biology to Therapies)
Leukemia is persistently a significant cause of illness and mortality worldwide. Urolithins, metabolites of ellagic acid and ellagitannins produced by gut microbiota, showed better bioactive compounds liable for the health benefits exerted by ellagic acid and ellagitannins containing pomegranate and walnuts. Here, we assessed the potential antileukemic activities of both urolithin A and urolithin B. Results showed that both urolithin A and B significantly inhibited the proliferation of leukemic cell lines Jurkat and K562, among which urolithin A showed the more prominent antiproliferative capability. Further, urolithin treatment alters leukemic cell metabolism, as evidenced by increased metabolic rate and notable changes in glutamine metabolism, one-carbon metabolism, and lipid metabolism. Next, we evidenced that both urolithins equally promoted apoptosis in leukemic cell lines. Based on these observations, we concluded that both urolithin A and B alter leukemic cell metabolome, resulting in a halt of proliferation, followed by apoptosis. The data can be used for designing new combinational therapies to eradicate leukemic cells. View Full-Text
Keywords: urolithin; leukemia; ellagic acid; glutamine; one-carbon metabolism urolithin; leukemia; ellagic acid; glutamine; one-carbon metabolism
Show Figures

Figure 1

MDPI and ACS Style

Alzahrani, A.M.; Shait Mohammed, M.R.; Alghamdi, R.A.; Ahmad, A.; Zamzami, M.A.; Choudhry, H.; Khan, M.I. Urolithin A and B Alter Cellular Metabolism and Induce Metabolites Associated with Apoptosis in Leukemic Cells. Int. J. Mol. Sci. 2021, 22, 5465. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115465

AMA Style

Alzahrani AM, Shait Mohammed MR, Alghamdi RA, Ahmad A, Zamzami MA, Choudhry H, Khan MI. Urolithin A and B Alter Cellular Metabolism and Induce Metabolites Associated with Apoptosis in Leukemic Cells. International Journal of Molecular Sciences. 2021; 22(11):5465. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115465

Chicago/Turabian Style

Alzahrani, Abdulaziz M., Mohammed R. Shait Mohammed, Raed A. Alghamdi, Abrar Ahmad, Mazin A. Zamzami, Hani Choudhry, and Mohammad I. Khan 2021. "Urolithin A and B Alter Cellular Metabolism and Induce Metabolites Associated with Apoptosis in Leukemic Cells" International Journal of Molecular Sciences 22, no. 11: 5465. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115465

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop